Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Jun 5;21(1):52.
doi: 10.1186/s12969-023-00826-7.

HLA-B*27 is associated with CNO in a European cohort

Affiliations
Meta-Analysis

HLA-B*27 is associated with CNO in a European cohort

Daire O'Leary et al. Pediatr Rheumatol Online J. .

Abstract

Objectives: To determine the influence of HLA-B27 positivity on risk of developing chronic nonbacterial osteomyelitis (CNO).

Methods: HLA-B*27 genotype was assessed in 3 European CNO populations and compared with local control populations (572 cases, 33,256 controls). Regional or whole-body MRI was performed at diagnosis and follow-up in all cases which reduces the risk of disease misclassification. Genotyping was performed using either next generation DNA sequencing or PCR based molecular typing. Statistical analysis used Fisher's exact test with Bonferroni correction and a fixed effects model for meta-analysis of odds ratios.

Results: HLA-B*27 frequency was higher in all 3 populations compared with local controls (combined odds ratio (OR) = 2.2, p-value = 3 × 10-11). This association was much stronger in male compared with female cases (OR = 1.99, corrected p-value = 0.015). However, the HLA-B*27 status was not statistically significantly associated with co-occurrence of psoriasis, arthritis or inflammatory bowel disease.

Conclusion: Carriage of HLA-B*27 is associated with greater risk of developing CNO, particularly in male cases.

Keywords: CNO; CRMO; Chronic nonbacterial osteomyelitis; HLA; Paediatric rheumatology.

PubMed Disclaimer

Conflict of interest statement

No potential conflicts of interest relevant to this article were reported by any of the authors.

Figures

Fig. 1
Fig. 1
HLA-B*27 is associated with CNO. Forest plot of pooled odds ratios using a fixed effects model (p = 3.07 × 10–11)

References

    1. Wipff J, Costantino F, Lemelle I, Pajot C, Duquesne A, Lorrot M, et al. A large national cohort of French patients with chronic recurrent multifocal osteitis. Arthritis Rheumatol. 2015;67(4):1128–1137. doi: 10.1002/art.39013. - DOI - PubMed
    1. Schnabel A, Range U, Hahn G, Berner R, Hedrich CM. Treatment response and longterm outcomes in children with chronic nonbacterial osteomyelitis. J Rheumatol. 2017;44(7):1058–1065. doi: 10.3899/jrheum.161255. - DOI - PubMed
    1. Skrabl-Baumgartner A, Singer P, Greimel T, Gorkiewicz G, Hermann J. Chronic non-bacterial osteomyelitis: a comparative study between children and adults. Pediatr Rheumatol Online J. 2019;17(1):49. doi: 10.1186/s12969-019-0353-2. - DOI - PMC - PubMed
    1. Zhao Y, Wu EY, Oliver MS, Cooper AM, Basiaga ML, Vora SS, et al. Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal Lesions. Arthritis Care Res. 2018;70(8):1228–1237. doi: 10.1002/acr.23462. - DOI - PMC - PubMed
    1. Miettunen PM, Wei X, Kaura D, Reslan WA, Aguirre AN, Kellner JD. Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO) Pediatr Rheumatol Online J. 2009;7:2. doi: 10.1186/1546-0096-7-2. - DOI - PMC - PubMed

Publication types